Fundz

Myosin Therapeutics Closes Seed Round To Continue Development Of Innovative Therapies For Glioblastoma And Stimulant Use Disorder

PRIVATEMar 14, 2023

Round Type

Seed

JupiterHealthcareHealth Care

Description

Myosin Therapeutics Inc., a biotechnology company leveraging its innovative platform technology to identify new molecular entities capable of selectively targeting nanomotor proteins, announced today that it supplemented its National Institutes of Health (NIH) funding with a seed funding round to advance the company's lead programs on glioblastoma and stimulant use disorder.

Quick answer

Myosin Therapeutics raised an undisclosed amount in a Seed round, dated March 14, 2023. Myosin Therapeutics is based in Jupiter, Florida, United States.

How much did Myosin Therapeutics raise?
Myosin Therapeutics raised an undisclosed amount in a Seed round on March 14, 2023.
What does Myosin Therapeutics do?
Myosin Therapeutics is a pioneering nanomotor platform company dedicated to improving health outcomes through novel pharmacotherapies targeting the myosin family of molecular motors.
Where is Myosin Therapeutics based and how big is it?
Myosin Therapeutics is based in Jupiter, Florida, United States. Fundz records about 8 employees.
Who are the decision-makers at Myosin Therapeutics?
Fundz holds 1 contact at Myosin Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Myosin Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • VeraDermics raised $15M on April 25, 2023.
  • ivWatch raised $27M on April 24, 2023.
  • Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
  • Eximis Surgical raised $8.7M (Funding Round) on April 24, 2023.
  • Convergent Dental raised $50M (Funding Round) on April 24, 2023.
  • Revbio raised $187K (Pre-Seed) on April 24, 2023.

Who to call at Myosin Therapeutics, and when

A new round usually means Myosin Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Myosin Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Myosin Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Myosin Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Myosin Therapeutics

Location

130 SCRIPPS WAY, 3B3

Jupiter, Florida, United States

About

Myosin Therapeutics is a pioneering nanomotor platform company dedicated to improving health outcomes through novel pharmacotherapies targeting the myosin family of molecular motors. As the first nMotor-driven oncology company, Myosin leverages its proprietary drug discovery system to develop a robust pipeline of therapeutics. This includes a groundbreaking treatment for Glioblastoma (GBM)—a critical unmet need affecting at least 10,000 patients annually in the U.S.—and a unique neurotherapeutic aimed at preventing relapse in METH use disorder, for which no FDA-approved medications currently exist. Beyond these, Myosin’s research into NMII-targeting pharmacotherapies holds promise across multiple areas, including cancer, substance use disorders, neural regeneration, and infectious diseases, driving forward both therapeutic innovation and scientific discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Myosin Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Myosin Therapeutics's next move

See what Strategic adds

Myosin Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.